
Prominent San Diego biotech agency Canale acquired by billion-dollar communications group
The local agency, founded by industry leader Carin Canale-Theakston, has been embedded in San Diego’s biotech scene for nearly a decade […]
The local agency, founded by industry leader Carin Canale-Theakston, has been embedded in San Diego’s biotech scene for nearly a decade […]
San Diego Union Tribune biotech reporter Bradley Fikes died November 21st, please join us for his memorial service.https://www.sandiegouniontribune.com/news/science/story/2019-11-21/beloved-union-tribune-biotech-writer-bradley-j-fikes-dies-at-62 &… […]
Details and registration https://sdsbdc.ecenterdirect.com/events/12511
From Dec 09, 2019 11:30AM to Dec 09, 2019 01:30PM at […]
Details and registration https://sdsbdc.ecenterdirect.com/events/12423
From Dec 11, 2019 05:30PM to Dec 11, 2019 08:30PM at […]
See https://www.thesdangels.com/entrepreneur/ to apply
From Dec 18, 2019 12:00AM to Dec 19, 2019 12:00AM at […]
It?s that time of year again! The WIB-Southern California Chapter would be delighted to have you join us for appetizers, dessert, drinks, some laughs, and tunes to celebrate the holiday season. Members, non-members, and friends are invited to our holid… […]
Paul Brennan
? Regenerative medicine company, NervGen Pharma ? focused on the treatment of nerve damage ? has tapped Paul Brennan to head the helm of the company as CEO and president. Brennan is the successor to Ernest Wong, who will continue to serve … […]
LA JOLLA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today a… […]
La Jolla Pharmaceutical is turning its focus to its lone FDA-approved product and another one in the pipeline after an experimental drug for a rare blood disease failed a late-stage study. On Monday, La Jolla Pharma (NASDAQ: LJPC) said it was halting a… […]
Science. ]]>
[…]
Phoenix Molecular Designs, a biotech developing kinase inhibitors to treat cancer, has brought in an undisclosed amount of financing?boosting its total seed funding raised to $12 million. The San Diego-based biotech says the proceeds will help fund the… […]
Months after touting how LJPC-401 appears to significantly lower excess iron levels in a small study involving patients with hereditary hemochromatosis, La Jolla Pharmaceutical is reconsidering its plans as the drug flopped for beta thalassemia patient… […]
Months after touting how LJPC-401 appears to significantly lower excess iron levels in a small study involving patients with hereditary hemochromatosis, La Jolla Pharmaceutical is reconsidering its plans as the drug flopped for beta thalassemia patient… […]
In startup world these days, the word ?biotech? is increasingly accompanied by ?computational? and two, two-letter initialisms: AI and ML. Those tools?artificial intelligence and machine learning, respectively?have been around for decades, but in recen… […]
? San Diego-based Adamis $ADMP saw its shares crater on the news that the FDA has rejected its application to market high-dose naloxone injection for the treatment of opioid overdose. The stock dropped about 50%, falling deep into penny stock territory… […]
BOSTON and CARLSBAD, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced initiation of the NEURO… […]
SAN DIEGO, Nov. 25, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento” or the ?Company?), confirmed today that on November 23, 2019, it received an unsolicited, non-binding term sheet proposal submitted by two biopharmaceu… […]
LA JOLLA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial and … […]
LA JOLLA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial and … […]
The SDSU graduate was known for his love of science and his extraordinary ability to explain […]
LA JOLLA?Salk Professors Joanne Chory, Joseph Ecker, Ronald Evans, Rusty Gage, Juan Carlos Izpisua Belmonte, Terrence Sejnowski and Reuben Shaw have been named to the?Highly Cited Researchers list?by Clarivate Analytics. The list selects researchers fo… […]
LA JOLLA?Although alcohol use is ubiquitous in modern society, only a portion of individuals develop alcohol use disorders or addiction. Yet, scientists have not understood why some individuals are prone to develop drinking problems, while others are n… […]
Hesaam Esfandyarpour holds what looks like a mini-cooler up to the computer screen in his California office.
Esfandyarpour is in his late-30s, with crows feet creeping up against a youthful face. He wears a gray polo and the device in his hand ? with i… […]
Cell study, extra DNA scooped up and copied alongside cancer-causing genes helps keep tumors going ? elements that could represent new drug targets for brain tumors and other cancers notoriously difficult to trea… […]
SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (?Axiom?), premier provider of unified eClinical solutions and services will be sponsoring The San Diego Entrepreneurs Exchange (?SDEE?) Happy Hour, a monthly event that aims to cre… […]
SAN DIEGO–(BUSINESS WIRE)—- $ILMN #ILMN–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast. Evercore ISI HealthCONx Conference in … […]
Paul Bromann is a Senior Manager of Scientific Affairs at Illumina. He also hosts the Illumina Genomics podcast. In this episode he explains why Illumina started a podcast and what the goals are. Because he […]
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio announces publication in the journal Nature elucidating the role of extrachromosomal DNA (ecDNA) structure in cancer biology. […]
Copyright © 2022 Biotech Networks, LLC